Journal Article Summary
The article investigates the use of ticagrelor, a medication that helps prevent blood clots, in patients experiencing acute myocardial infarction (AMI), commonly known as a heart attack. This topic is significant because ticagrelor has been shown to be more effective than clopidogrel, another antiplatelet medication, but its effectiveness can be reduced when used with high doses of aspirin. Understanding the current patterns of ticagrelor use and the factors influencing its prescription can help improve treatment strategies for heart attack patients.
The study analyzed data from over 167,000 patients with AMI who were part of the ACTION Registry-Get With The Guidelines between October 2013 and December 2014. Researchers looked at how often ticagrelor was prescribed at discharge and identified factors that influenced its use compared to other medications like clopidogrel and prasugrel. They found that the prescription rate of ticagrelor increased from 12% to 16.7% during the study period, and most patients were discharged on low-dose aspirin, which aligns with recommended guidelines.
However, the study has limitations, including that it only reflects practices from larger hospitals participating in the registry, which may not represent community hospitals. Additionally, the data is based on hospital stays and does not include long-term outcomes or follow-up information. Patients should discuss their treatment options and any concerns about medications like ticagrelor and aspirin with their healthcare providers to ensure they receive the best care tailored to their individual needs.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Basra Sukhdeep S., Wang Tracy Y., Simon DaJuanicia N., Chiswell Karen, Virani Salim S., Alam Mahboob, Nambi Vijay, Denktas Ali E., et al.. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2018. DOI: 10.1161/JAHA.117.008125. PMID: 29886424. PMCID: PMC6220549.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
